BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 8, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 22, 2018
View Archived Issues
Bayer patents Wnt signaling and/or tankyrase-1/2 inhibitors
Read More
Accent Therapeutics launches to create innovative therapeutics in area of epitranscriptomics
Read More
Docetaxel nanoemulsion with theranostic properties selectively targets ovarian cancer cells
Read More
Wuhan Bowo Biological Technology divulges pneumococcal protein vaccines
Read More
FDA approves thrombopoietin receptor agonist Doptelet
Read More
European Commission approves Juluca for HIV-1
Read More
FDA awards breakthrough therapy and fast track designations to Harmony's pitolisant
Read More
Prolia approved in U.S. for glucocorticoid-induced osteoporosis
Read More
Lundbeck begins clinical development with PDE1 inhibitor Lu-AF-76432
Read More
New anticancer adaptive cell therapy approach as cancer immunotherapeutic shows promise
Read More
FDA approves Lokelma for hyperkalemia
Read More
KRAS-G12C inhibitors reveal new approach to undruggable targets
Read More
FDA accepts NDA for Rifamycin SV MMX
Read More
Merck & Co.'s rVSV-ZEBOV Ebola vaccine deployed in Democratic Republic of Congo
Read More
Immunomedics submits BLA for sacituzumab govitecan for metastatic TNBC
Read More
Genentech presents first phase I data for BITS-7201A
Read More
AstraZeneca files for Japanese approval of Forxiga for type 1 diabetes
Read More
MHRA clears 4D pharma to begin phase Ib study of MRx-0518
Read More
First-in-human study shows promise of SYNT-001 in pemphigus
Read More
Glenmark submits NDA for Ryaltris for seasonal allergic rhinitis
Read More
Allergy Therapeutics reports promising topline results from phase II trial of Grass MATA MPL
Read More
New company Curevo to support GC Pharma's vaccine development work
Read More
Gilead Sciences seeks Japanese approval of sofosbuvir/velpatasvir
Read More